GE Healthymagination Fund

The GE Healthymagination Fund is a corporate venture capital fund established by General Electric (GE) to invest in innovative healthcare companies. Its mission is to improve the quality, access, and affordability of healthcare worldwide by supporting emerging companies with promising technologies and business models. The fund is part of GE's broader healthymagination initiative, a $6 billion commitment launched in 2009 to address global health challenges through innovation. The fund focuses on three primary areas: broad-based diagnostics, healthcare information technology, and life sciences. Investments target technologies such as imaging, home health, patient monitoring, molecular diagnostics, pathology, novel imaging agents, electronic medical records, clinical information systems, and tools for drug discovery and biopharmaceutical manufacturing. By leveraging GE's extensive resources, including GE Healthcare, GE Capital, and GE Global Research, the fund aims to accelerate the development and adoption of these technologies globally. Since its inception, the GE Healthymagination Fund has made several notable investments, including in NanoString Technologies, a company specializing in molecular diagnostics, and C8 MediSensors, a developer of non-invasive continuous glucose monitors. These investments align with the fund's strategy to support companies that can significantly impact healthcare delivery and outcomes. Through these efforts, the fund continues to contribute to GE's vision of transforming healthcare through innovation and collaboration.

Innovative healthcare technologies, Scalable business models, Alignment with GE's healthymagination initiative